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Taking the Last Hurdles: Magnetic Resonance
Myocardial Perfusion Imaging*
Eike Nagel, MD, PHD
London, United KingdomIn this issue of iJACC, Doesch et al. (1) assess the
prognostic value of magnetic resonance (MR) aden-
osine stress perfusion in patients with coronary
lesions of 50% but 75%. This study closes an
important gap in the decision-making process and
may reduce the need for invasive hemodynamic
studies in patients with intermediate stenoses.
The selection of patients with stable coronary
artery disease (CAD) for invasive coronary angiog-
raphy and revascularization and the prediction of
the individual patient’s risk of major cardiac events
remain subjective and imprecise. Recent invasive
studies, such as the DEFER (Deferral Versus Per-
formance of PTCA in Patients Without Docu-
mented Ischemia) study have shown that revascu-
larization does not improve the prognosis of
See page 424
patients with intermediate coronary artery stenosis,
if the stenosis does not limit flow during stress (2).
Usually, this is determined by measuring pressure
proximal and distal to the stenosis using an intracoro-
nary pressure wire (fractional flow reserve [FFR]).
These single-center data have been reconfirmed in a
multicenter setting in patients with multivessel dis-
ease, in the FAME (Fractional Flow Reserve Versus
Angiography for Multivessel Evaluation) study (3).
Among others, the COURAGE (Clinical Outcomes
Utilizing Revascularization and Aggressive Drug
Evaluation) trial has challenged the benefit of revas-
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
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vascular Imaging or the American College of Cardiology.
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Daiichi-Sankyo.cularizing patients with stable angina pectoris as a
whole (4). A subgroup analysis of the COURAGE
data in patients with single-photon emission com-
puted tomography (SPECT) suggests that the prog-
nosis of patients is correlated to their ischemic burden
after optimal medical therapy (with or without revascu-
larization) and the amount of ischemia reduction
achieved by therapy (5). That is in line with a wealth
of data demonstrating that the prognosis of patients is
related to the presence of stress-induced myocardial
ischemia using SPECT (6–10), stress echocardiog-
raphy (11–14), or cardiac MR (15,16). Specific data
on patients with intermediate stenoses, however,
are lacking.
Over the past 3 decades, SPECT and positron
emission tomography (PET) have dominated myocar-
dial perfusion imaging in clinical practice on the basis
of an extensive amount of research. However, these
techniques have several important limitations, such as
the occurrence of attenuation artifacts for SPECT, the
application of radioactive tracers, and the limited
availability of PET, which is considered the reference
standard. MR myocardial perfusion imaging has been
shown to be highly accurate for the assessment of
myocardial ischemia and was noninferior to SPECT
in a recent multicenter trial (17). One of the major
advantages of MR perfusion imaging is its ability to
visualize subendocardial perfusion defects, which is
not possible with PET or SPECT owing to their
lower spatial resolution. More recently, MR perfusion
imaging has been validated against invasive hemody-
namic measurements, resulting in good correlations
with coronary flow reserve and acceptable correlations
with FFR (18–20).
To date, less clinical outcome information is
available from MR myocardial perfusion imaging in
comparison to nuclear medicine, which has been
used for 30 years. However, these data are be-
coming available. A recent study (8) of adenosine
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435tress perfusion cardiac MR in patients with chest
ain, negative troponin-I test results, and nondiag-
ostic electrocardiographic findings demonstrated a
ensitivity of 100% and a specificity of 93% for the
etection of future adverse cardiac outcomes. Pa-
ients with normal stress myocardial perfusion had
o adverse cardiac events during 1 year of follow-
p. In another study by Jahnke et al. (16), a negative
erfusion study was related with 0.7%, 0.7%, and
.3% cumulative event rate for the first 3 years,
hich was significantly lower than the event rate in
atients with a positive MR myocardial perfusion
tudy (6.2%, 12.2%, and 16.3% cumulative event
ate for the first 3 years).
Doesch et al. (1) have followed up a group of 81
atients with stable angina and intermediate coro-
ary artery lesions by invasive angiography for 30
months. All patients were treated with optimal
edical therapy independent of the MR findings.
n the group of 36 patients without a defect on
denosine stress MR perfusion, no major cardiac
vent was found during a follow-up period of 30 
months. In contrast, in the group of 45 patients
ith a perfusion defect, 9 (20%) had an acute
oronary syndrome. Despite not being used for
linical decision making, the presence of a stress-
nduced perfusion defect was associated with a
ignificantly higher rate of revascularization (37.8%
s. 5.5%). The presence or absence of a perfu-without percutaneous coronary inter- Cardiol 2006;47:14ollow-up at 18  8 months, but not at a late
ollow-up.
The study closes a growing gap. On one hand,
evascularization should be restricted to patients
ith hemodynamically significant stenoses. Until
ow, the only evidence specifically for patients with
ntermediate stenoses was available for FFR, which
ither requires a second invasive procedure after the
rst diagnostic angiography, or a significant prolon-
ation of the invasive study. On the other hand, the
umber of patients with a primary diagnosis based
n multislice computed tomography is also increas-
ng. For both groups, a noninvasive rapid test would
e highly desirable. Based on the data from this
tudy, we can now start using MR perfusion in this
etting.
Future trials need to concentrate on several as-
ects. First, the data need to be reconfirmed in a
arger group of patients, preferably in a multicenter
etting. Second, it needs to be worked out whether
n MR perfusion-guided strategy is superior to an
R blind strategy. Third, a direct comparison of an
R-guided strategy to an FFR-guided strategy
eeds to be performed.
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t. Thomas’ Hospital, London SE1 7EH, United King-ion defect correlated with symptoms at an early dom. E-mail: eike.nagel@kcl.ac.uk.1
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